The health-related quality-of-life impact of histamine dihydrochloride plus interleukin-2 compared with interleukin-2 alone in patients with metastatic melanoma. (Q44421258)
Jump to navigation
Jump to search
scientific article published on 28 January 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | The health-related quality-of-life impact of histamine dihydrochloride plus interleukin-2 compared with interleukin-2 alone in patients with metastatic melanoma. |
scientific article published on 28 January 2003 |
Statements
The health-related quality-of-life impact of histamine dihydrochloride plus interleukin-2 compared with interleukin-2 alone in patients with metastatic melanoma (English)
Kathleen M Beusterien
Stacey J Ackerman
Kathryn Plante
John Glaspy
Diana Wood
Kurt Gehlsen
Sanjiv S Agarwala
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference